Medication info
Telmisartan and Amlodipine Tablets 40/10 mg

Telmisartan and Amlodipine Tablets 40/10 mg

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Handok Co., Ltd.
Appearance
Biconvex oval double coated tablet, white and light gray in color
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201605771 · Approved 2016.09.30 · Insurance code 652105630

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, as follows, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
○ Pediatric patients: As the safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger, its use is not recommended.

Ingredients

Manufacturer
Handok Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower and control blood pressure in patients with essential hypertension who have not achieved adequate blood pressure control with monotherapy of Amlodipine or Telmisartan.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, as follows, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

○ Pediatric patients: As the safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger, its use is not recommended.

Precautions

This drug can cause serious harm to the fetus during pregnancy, especially in the second and third trimesters, therefore it should not be taken by women who are pregnant or may become pregnant. Patients with allergies to any components of this drug, liver impairment, severe hypotension, or heart-related diseases should avoid its use. Patients with poor liver function or specific heart valve diseases should exercise special caution when using this drug. Patients with gastrointestinal diseases or kidney function issues should also be cautious when taking this drug and should regularly monitor blood pressure and kidney function. This drug has a blood pressure-lowering effect, which may lead to symptoms of hypotension, therefore patients at risk for hypotension should consult with a healthcare professional before use. Patients may experience symptoms such as dizziness or drowsiness while taking this medication, hence caution is needed when driving or operating hazardous machinery. This drug may interact with other blood pressure medications or lithium, digoxin, etc., so if you are taking other medications, be sure to inform your doctor or pharmacist. It is advisable for breastfeeding women to avoid taking this medication, and pregnant women should discontinue as soon as possible. Safety and efficacy have not been sufficiently established for children or adolescents under 18 years of age, thus it is not recommended for this group. Overdose can lead to severe hypotension or heart problems, so it is important to adhere strictly to the prescribed dosage and seek immediate medical attention if unusual symptoms occur. This drug should be stored out of reach of children and kept away from moisture.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbances
  • sensory loss
  • taste disturbances
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • double vision
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • intestinal air distension
  • vomiting
  • dry mouth
  • gum hypertrophy
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver disorders
  • hepatitis
  • jaundice
  • increased liver enzymes
  • itching
  • sweating
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • frequent urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a tightly sealed container that blocks light. Furthermore, to maintain the drug's efficacy, it is important to store it at room temperature, between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Biconvex oval double coated tablet, white and light gray in color

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.